Plasminogen activator inhibitor 1 (PAI-1) has been shown to reduce myocardial fibrosis and promote M2 macrophage polarization in inflammatory cardiomyopathy (Baumeier et al., 2021). The gene discussed is SERPINE1; the disease is Myocardial fibrosis.